You are here: Industry Insights > powder inhaler

News List

Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio pharmafocusasia
November 12, 2018
Vectura Group plc, today announces signing an agreement with Hikma Pharmaceuticals PLC ("Hikma") for the global development and commercialisation of generic versions of GSK’s Ellipta® portfolio, utilising Vectura’s proprietary Open-Inhale-Close dry powder
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio pharmafocusasia
November 12, 2018
Vectura Group plc, today announces signing an agreement with Hikma Pharmaceuticals PLC ("Hikma") for the global development and commercialisation of generic versions of GSK’s Ellipta® portfolio, utilising Vectura’s proprietary Open-Inhale-Close dry powder
Glenmark to market Tiotropium Bromide dry powder inhaler in Western Europe expressbpd
August 30, 2018
Glenmark Pharmaceuticals Europe has entered into a strategic, exclusive licensing agreement for marketing generic Tiotropium Bromide dry powder inhaler, used in the treatment of chronic obstructive pulmonary disease, in Western Europe.